Intas Pharmaceuticals Ltd - Company Profile
Powered by
All the data and insights you need on Intas Pharmaceuticals Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Intas Pharmaceuticals Ltd Strategy Report
- Understand Intas Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Intas Pharmaceuticals Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4055005A1 | Application | FLÜSSIGE MELPHALANZUSAMMENSETZUNG | A61K31/198; A61K47/02; A61K47/10; A61K47/12; A61K47/20; A61K9/0019; A61K9/08; A61P35/00; C07C227/44 | September 14, 2022 |
US11433058B2 | Grant | Non-pulsatile prolonged-release betahistine oral solid compositions | A61K31/4402; A61K9/0053; A61K9/2009; A61K9/2013; A61K9/205; A61K9/2054; A61K9/2072; A61K9/2095 | September 06, 2022 |
WO2022180582A1 | Application | ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE | September 01, 2022 | |
US20220273646A1 | Application | PHARMACEUTICAL COMPOSITION OF TEMOZOLOMIDE | A61K31/495; A61K47/02; A61K47/10; A61K47/12; A61K9/0095 | September 01, 2022 |
US20220273645A1 | Application | NALTREXONE FORMULATION | A61K31/485; A61K9/0056 | September 01, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer